Literature DB >> 148342

The antibody response of institutionalized Down's syndrome patients to seven microbial antigens.

R A Hawkes, C R Boughton, D R Schroeter.   

Abstract

An earlier cross-sectional study had revealed that institutionalized Down's syndrome (DS) patients possessed much lower titres of hepatitis B surface antibodies (anti-HBs) than did their non-Down's (ND) counterparts. In an attempt to determine whether DS patients were generally deficient in humoral antibody response, the inmates of an institution for the mentally retarded (110 DS, seventy-eight ND) were immunized with tetanus, diphtheria (toxoids), influenza A, influenza B (inactivated vaccines), measles, mumps and rubella (attenuated vaccines), and tested for their antibody responses. The DS and ND groups did not respond differently to any of the seven antigens. Furthermore, there was no general relationship between the anti-HBs titres of inmates and their capacity to respond to the defined antigenic stimulus of any of the seven antigens. From these results it is apparent that a general humoral deficit in the DS group cannot explain their tendency to possess much lower anti-HBs titres than their ND counterparts upon becoming infected with the hepatitis B virus. When the antibody status and responses to immunization of the inmates who possessed anti-HBs were compared with those who had chronic HBsAg antigenaemia, there was no significant difference between the groups.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 148342      PMCID: PMC1541221     

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  9 in total

1.  Defective antibody response to bacteriophage phichi 174 in Down syndrome.

Authors:  V Lopez; H D Ochs; H C Thuline; S D Davis; R J Wedgwood
Journal:  J Pediatr       Date:  1975-02       Impact factor: 4.406

2.  A field study in triple immunization (diphtheria, pertussis, tetanus). Estimation of 3 antibodies in infant sera from a single heel puncture using agglutination techniques.

Authors:  L LEVINE; L WYMAN; E J BRODERICK; J IPSEN
Journal:  J Pediatr       Date:  1960-12       Impact factor: 4.406

3.  Mongols and non-mongols compared in their response to active tetanus immunisation.

Authors:  A W Griffiths; P E Sylvester
Journal:  J Ment Defic Res       Date:  1967-12

4.  A serum antigen (Australia antigen) in Down's syndrome, leukemia, and hepatitis.

Authors:  B S Blumberg; B J Gerstley; D A Hungerford; W T London; A I Sutnick
Journal:  Ann Intern Med       Date:  1967-05       Impact factor: 25.391

5.  Australia antigen and the immune response in human diseases.

Authors:  A I Sutnick
Journal:  J Allergy Clin Immunol       Date:  1974-01       Impact factor: 10.793

6.  Antibody responses to influenza vaccine in patients with Down's syndrome.

Authors:  M C Gordon; S K Sinha; S D Carlson
Journal:  Am J Ment Defic       Date:  1971-01

7.  Effects of host and environment on immunoglobulins in Down's syndrome.

Authors:  A I Sutnick; W T London; B S Blumberg
Journal:  Arch Intern Med       Date:  1969-12

8.  Hemagglutination assay for antigen and antibody associated with viral hepatitis.

Authors:  G N Vyas; N R Shulman
Journal:  Science       Date:  1970-10-16       Impact factor: 47.728

9.  The epidemiology of hepatitis B in a residential institution for the mentally retarded.

Authors:  C R Boughton; R A Hawkes; D R Schroeter; J A Harlor
Journal:  Aust N Z J Med       Date:  1976-12
  9 in total
  6 in total

1.  Immunological and purine enzyme studies on hyperuricaemic and normouricaemic patients with Down's syndrome.

Authors:  R W Watts; Y S Perera; J Allsop; C Newton; T A Platts-Mills; A D Webster
Journal:  Clin Exp Immunol       Date:  1979-06       Impact factor: 4.330

2.  Safety and effectiveness of an acellular pertussis vaccine in subjects with Down's syndrome.

Authors:  S Li Volti; T Mattina; L Mauro; S Bianca; S Anfuso; A Ursino; F Mollica
Journal:  Childs Nerv Syst       Date:  1996-02       Impact factor: 1.475

3.  Antibody response to pneumococcal vaccine in patients with trisomy-21 (Down's syndrome).

Authors:  T Nurmi; M Leinonen; V M Häivä; A Tiilikainen; K Kouvalainen
Journal:  Clin Exp Immunol       Date:  1982-05       Impact factor: 4.330

4.  The response of institutionalized Down's syndrome subjects to enterovirus infections.

Authors:  R A Hawkes; S C Philbrook; C R Boughton
Journal:  J Hyg (Lond)       Date:  1980-06

5.  Hepatitis B infection in institutionalized Down's syndrome inmates: a longitudinal study with five hepatitis B virus markers.

Authors:  R A Hawkes; C R Boughton; D R Schroeter; R H Decker; L R Overby
Journal:  Clin Exp Immunol       Date:  1980-06       Impact factor: 4.330

6.  Inflammatory and Immunological parameters in adults with Down syndrome.

Authors:  Maria Bf Trotta; João B Serro Azul; Mauricio Wajngarten; Simone G Fonseca; Anna C Goldberg; Jorge E Kalil
Journal:  Immun Ageing       Date:  2011-04-16       Impact factor: 6.400

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.